Alternate-Day Buprenorphine Administration. Phase I - 3
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine if two times a subject's daily maintenance dose
will hold for 48 hours without changes in agonist and antagonist effects.